Literature DB >> 7621583

Activation of the endothelium by IL-1 alpha and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a.

M Coulpier1, S Andreev, C Lemercier, H Dauchel, O Lees, M Fontaine, J Ripoche.   

Abstract

Constitutive secretion of complement C3 and factor B by the endothelial cell (EC) is lowered by therapeutic concentrations of glucocorticoids such as hydrocortisone or dexamethasone, whereas regulatory protein factor H production is increased by these hormones. In contrast, the proinflammatory cytokine IL-1 alpha has a stimulatory effect on C3 and factor B secretion by the endothelium and an inhibitory effect on factor H secretion. In this study, we examined the combined effect of IL-1 alpha and glucocorticoids on C3 and factor B expression by the endothelial cell. When dexamethasone or hydrocortisone were added to IL-1 alpha, significant potentialization of IL-1 alpha-induced stimulation of C3 and factor B production was observed, occurring at various concentrations of either stimuli. Dose-response experiments indicate that, in vitro, optimal concentrations are in the range of 10(-7) to 10(-5) M for dexamethasone and 50-200 U for IL-1 alpha. In contrast, dexamethasone counteracts, in an additive way, the inhibitory effect of IL-1 alpha on regulatory complement protein factor H production by EC. Such a potentialization between glucocorticoids and IL-1 alpha was not observed for another marker of endothelial activation, IL-1 alpha-induced stimulation of coagulation tissue factor expression. The association of glucocorticoids and IL-1 alpha therefore appears to be a specific and major stimulus for the secretion of complement C3 and factor B, two acute-phase proteins, by the endothelium. As a result of the in vitro endothelium stimulation by glucocorticoids and IL-1 alpha, C3a is generated in the vicinity of the endothelial cell. This study further suggests that complement activation, with its deleterious consequences, may result from the stimulation of endothelium in situations where high levels of IL-1 alpha and endogenous glucocorticoids coexist, such as in septic shock.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621583      PMCID: PMC1553312          DOI: 10.1111/j.1365-2249.1995.tb02290.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma.

Authors:  R A Brooimans; P S Hiemstra; A A van der Ark; R B Sim; L A van Es; M R Daha
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

2.  Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells.

Authors:  P J Knudsen; C A Dinarello; T B Strom
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

3.  Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells.

Authors:  S L Brown; L R Smith; J E Blalock
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

4.  In vivo administration of IL-1 induces thymic hypoplasia and increased levels of serum corticosterone.

Authors:  P J Morrissey; K Charrier; A Alpert; L Bressler
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

5.  Radioimmunoassay for dexamethasone in plasma.

Authors:  M Hichens; A F Hogans
Journal:  Clin Chem       Date:  1974-02       Impact factor: 8.327

6.  Glucocorticosteroid-dependent synergy between interleukin 1 and interleukin 6 for human B lymphocyte differentiation.

Authors:  D Emilie; M C Crevon; M T Auffredou; P Galanaud
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

7.  [Cleavage of the C3 component of complement in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC)].

Authors:  S V Andreev; A M Ishchenko; V A Pasechnik; S A Ketlinskiĭ; E V Karamov
Journal:  Dokl Akad Nauk SSSR       Date:  1987

8.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

Authors:  S Okusawa; J A Gelfand; T Ikejima; R J Connolly; C A Dinarello
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

9.  Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.

Authors:  S W Lee; A P Tsou; H Chan; J Thomas; K Petrie; E M Eugui; A C Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

10.  Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture.

Authors:  J Ripoche; J A Mitchell; A Erdei; C Madin; B Moffatt; T Mokoena; S Gordon; R B Sim
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  10 in total

1.  Glucocorticoids enhance or spare innate immunity: effects in airway epithelium are mediated by CCAAT/enhancer binding proteins.

Authors:  Ning Zhang; Quynh Ai Truong-Tran; Brian Tancowny; Kathleen E Harris; Robert P Schleimer
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

2.  Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury.

Authors:  Kunal J Patel; Qi Cheng; Sarah Stephenson; D Patterson Allen; Changhai Li; Jane Kilkenny; Ryan Finnegan; Valeria Montalvo-Calero; Scott Esckilsen; Chentha Vasu; Martin Goddard; Satish N Nadig; Carl Atkinson
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

3.  Mechanism of TH2/TH17-predominant and neutrophilic TH2/TH17-low subtypes of asthma.

Authors:  Weimin Liu; Sucai Liu; Mukesh Verma; Iram Zafar; James T Good; Donald Rollins; Stephen Groshong; Magdalena M Gorska; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2016-10-01       Impact factor: 10.793

4.  Nonstructural Protein 1 of Variant PEDV Plays a Key Role in Escaping Replication Restriction by Complement C3.

Authors:  Baochao Fan; Qi Peng; Shiying Song; Danyi Shi; Xue Zhang; Weilu Guo; Yunchuan Li; Jinzhu Zhou; Xuejiao Zhu; Yongxiang Zhao; Rongli Guo; Kongwang He; Huiying Fan; Siyuan Ding; Bin Li
Journal:  J Virol       Date:  2022-08-29       Impact factor: 6.549

5.  Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response.

Authors:  Fatoumata B Sow; Jack M Gallup; David K Meyerholz; Mark R Ackermann
Journal:  Dev Comp Immunol       Date:  2009-02-02       Impact factor: 3.636

6.  Pro-inflammatory cytokines from Kupffer cells downregulate hepatocyte expression of adrenomedullin binding protein-1.

Authors:  Asha Jacob; Mian Zhou; Rongqian Wu; Vivienne J Halpern; Thanjavur S Ravikumar; Ping Wang
Journal:  Biochim Biophys Acta       Date:  2007-04-06

7.  Differential regulation of endothelial cell activation by complement and interleukin 1alpha.

Authors:  Gregory J Brunn; Soheyla Saadi; Jeffrey L Platt
Journal:  Circ Res       Date:  2006-03-02       Impact factor: 17.367

8.  Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea.

Authors:  Pierfrancesco Mirabelli; Anthony Mukwaya; Anton Lennikov; Maria Xeroudaki; Beatrice Peebo; Mira Schaupper; Neil Lagali
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

9.  Acute murine antigen-induced arthritis is not affected by disruption of osteoblastic glucocorticoid signalling.

Authors:  Cornelia M Spies; Edgar Wiebe; Jinwen Tu; Aiqing Li; Timo Gaber; Dörte Huscher; Markus J Seibel; Hong Zhou; Frank Buttgereit
Journal:  BMC Musculoskelet Disord       Date:  2014-02-03       Impact factor: 2.362

10.  AICAR suppresses TNF-α-induced complement factor B in RPE cells.

Authors:  Eun Jee Chung; Nikolaos E Efstathiou; Eleni K Konstantinou; Daniel E Maidana; Joan W Miller; Lucy H Young; Demetrios G Vavvas
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.